Cytokinetics Stock Price (NASDAQ:CYTK)

Add to My Stocks
$12.55 $0.25 (1.95%) CYTK stock closing price Mar 23, 2017 (Closing)
23 MAR 2017
amigobulls logo
CYTK hand_up
CYTK vs S&P 500
Closing Price: Mar 23, 2017
$12.55 ( -1.95%)
S&P 500
2346 ( -0.11%)
52 Week Price Range
1 Year Return: 96.02%
Q4 Growth*
Profitable ?
net image
2016 Q4 Net Profit
PE Valuation
home image
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen

Cytokinetics Snapshot Video

13 5 2

CYTK Stock Details

Prev Close* : $12.80
Market Cap:
Day Low: $12.45
52 Week Low: $6.27
Open: $12.75
Volume: 281028
Day High: $13
52 Week High: $13.70

Latest Stock Market News

Latest Articles

Cytokinetics News - From Partners

What Took So Long?   by Zacks on Dec 29, 2016

CYTK Stockcharts

View CYTK PE ratio, PS ratio stocks charts and compare with peers.
CYTK Chart
Note: Compare Cytokinetics stock price history with the index and industry peers.

Cytokinetics Valuation

PE ratio
(price earnings ratio)
PS ratio (
price to sales ratio
PB ratio (
price to book ratio

CYTK Industry Peers

Company Price Change (%)
Revance (RVNC)19.850.5 (2.58%)
Regenxbio (RGNX)20.050.4 (1.96%)
Amgen (AMGN)166.041.41 (0.84%)
Voyager Therapeutics (VYGR)10.920.01 (0.09%)
Biogen Inc (BIIB)275.412.46 (0.89%)
Acorda Therapeutics (ACOR)25.40.15 (0.59%)
Ionis Pharma (IONS)38.140.1 (0.26%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
ALBIREO PHARMA (ALBO)23.783.48 (17.14%)
Trevena (TRVN)3.590.26 (7.81%)
Fate Therapeutics (FATE)4.640.24 (5.45%)
Sangamo BioSciences (SGMO)4.20.2 (5%)
Cara Therapeutics (CARA)16.690.6 (3.73%)
Lion Biotech (LBIO)7.40.25 (3.5%)
Immunomedics (IMMU)6.630.21 (3.27%)
Top gainers from Medical-Biomed-Genetics industry
* As of Mar 23, 2017
CompanyPriceChange (%)
Ultragenyx Pharma (RARE)71.996.37 (8.13%)
Stemline Therapeutics (STML)8.50.45 (5.03%)
Puma Biotech (PBYI)40.11.45 (3.49%)
MannKind (MNKD)1.950.07 (3.47%)
Emergent Biosolutions (EBS)28.361.01 (3.44%)
Five Prime Therapeutics (FPRX)34.891.16 (3.22%)
Idera Pharma (IDRA)2.420.07 (2.81%)
Top losers from Medical-Biomed-Genetics industry
* As of Mar 23, 2017

Cytokinetics, Inc. Stock News - Partner Headlines

Cytokinetics Financial Statements

income statement20162015201420132012
Net Sales Or Revenues106.41M28.65M46.94M30.64M7.55M
Net Income16.45M-37.5M-14.64M-33.71M-40.37M
Total Operating Expense-66.05M61.68M64.54M48.01M
view Cytokinetics, Inc. income statement
balance sheet20152014201320122011
Total Assets115.23M132.96M83.18M77.55M52.77M
Total Liabilities46.64M40.9M28.74M7.46M4.59M
Shareholders Equity68.59M92.06M54.44M70.08M48.17M
view Cytokinetics, Inc. balance sheet
cash flow statement20152014201320122011
Net Increase (Decrease) In Assets Liabilities37.24M-34.01M22.04M2.61M-2.29M
Net Cash From (Used By) Operating Activities4.88M-44.84M-7.71M-33.43M-45.59M
Increase (Decrease) In Prop Plant And Equipment-0.56M-1.1M-0.52M-0.12M-0.44M
view Cytokinetics, Inc. cashflow statement

Cytokinetics Stock Message Board

As of last trading day, Cytokinetics stock price was 12.8. Cytokinetics market capitalization is 509.11M and it represents the total market value of CYTK stock. Cytokinetics valuation can be guaged using various valuation metrics like the price to earnings ratio.

For recognizing and analyzing the real performance of Cytokinetics stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. The volume number in Cytokinetics stock quote data shows the number of shares traded. For Ex: 422009 Cytokinetics shares were traded as of last trading day, as seen from Cytokinetics stock chart. Cytokinetics stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.